Why Are Men Still Quiet About Using Weight-Loss Drugs?

A middle-aged/older American man looking at himself in a mirror, thoughtful rather than unhappy, with a subtle weight-management-depicting the psyche of men and weight-loss drugs

For years, men have been told that losing weight is mainly a test of discipline: eat less, exercise more and work harder.

But what happens when diet and exercise are no longer enough?

For many men living with obesity, losing substantial weight can become a difficult and frustrating process. Previous diets may stall, exercise may become harder, and health concerns can add urgency to the need to lose weight.

As GLP-1 medications become increasingly important in modern weight-management treatment, the conversation is moving beyond how much weight people lose to how they feel about the treatment itself.

Now, a new issue is emerging as GLP-1 medications become more widely used: many men may be taking weight-loss drugs without wanting anyone to know.

The reasons go beyond privacy. Some men fear being judged, others worry that medication makes their weight loss seem less legitimate, and some still see medical treatment as a shortcut rather than a legitimate part of obesity care.

Recent research suggests that this stigma is real. Studies published in 2026 found that people can judge GLP-1-assisted weight loss more negatively than weight loss achieved through diet and exercise, reinforcing the idea that medication users have taken an easier route.

So why are men still quiet about using weight-loss drugs — even when these medications may be helping them achieve something they have struggled with for years?

Why are so many men still reluctant to talk about taking weight-loss drugs?

A recent BBC report highlighted men who privately use medicines such as Wegovy and Mounjaro but feel uncomfortable discussing them publicly.

Their reasons are revealing.

Some fear judgment. Others worry that people will consider their weight loss a shortcut. Some are concerned about side effects or cost. Others simply believe that needing medication means they have failed at controlling their weight themselves.

But obesity is a chronic health condition. Seeking medical treatment is not a failure.

The Changing Face of Weight Loss

GLP-1-based medications have changed the obesity-treatment conversation.

In the United States, medications such as Wegovy (semaglutide) and Zepbound (tirzepatide) are approved for appropriate patients as part of a broader weight-management approach that includes diet and physical activity.

That is an important distinction.

These medicines are not designed to replace healthy eating or physical activity.

They are medical tools that can help eligible patients manage a condition that may be extremely difficult to control through lifestyle changes alone.

Yet some men still see medication as admitting defeat.

“I Should Be Able to Do This Myself”

This attitude may be particularly powerful among men.

The traditional image of male fitness emphasizes strength, discipline and self-reliance.

For some men, admitting that they need medication for weight management can therefore feel uncomfortable.

The BBC report illustrated this through several men’s experiences. Steffen Peddie, who had reached more than 35 stone, said he initially felt weak for needing a weight-loss injection even after already losing substantial weight through dieting.

That feeling is important because it shows that the problem is not necessarily a lack of motivation.

Sometimes it is the belief that asking for medical help means you have failed.

It doesn’t.

The “Cheating” Label Can Be Powerful

Another recurring concern is the idea that weight-loss medications are somehow cheating.

Men interviewed in the BBC report described this attitude directly. One man said he worried about using the injections because he viewed them as a “cheat’s way out.”

But this argument overlooks something important.

We do not normally describe medication for high blood pressure as cheating.

We do not call cholesterol medication cheating.

We do not expect someone with asthma to control the condition through willpower alone.

Obesity treatment can involve medication for the same basic reason: some health conditions require medical treatment.

New Research Shows That the Stigma Is Real

This is not only anecdotal.

Recent research examining attitudes toward anti-obesity medications found that people using GLP-1 medicines can face negative judgments because others may believe they exerted less effort to lose weight.

Researchers described this as an “effort-based” bias surrounding anti-obesity medication. (PubMed Central (PMC))

Another 2025 study examined public attitudes toward newer anti-obesity medications and the belief that obesity reflects a failure of willpower.

That research highlights an important shift in the way obesity is understood: increasingly, obesity is being viewed through both biological and medical lenses rather than simply as a question of personal discipline.

For men, this change may be particularly significant.

What Men in the BBC Report Experienced

The experiences described in the BBC report show how secrecy can change once men discover that others are doing exactly the same thing.

Peddie asked men to share their experiences of weight-loss drugs on Facebook.

Around 20 men responded publicly, while more than 70 contacted him privately.

Many had obtained their medication through private pharmacies and had not told many people they were using it.

One man, Barry, initially kept his treatment private. After discussing Mounjaro with colleagues, he discovered that several others were using weight-loss medication too.

That pattern says something important.

The number of men using these medications may be larger than the number willing to talk about them.

Why Men May Keep Weight-Loss Treatment Private

Several factors can contribute to the silence.

1. Fear of Looking Weak

Some men associate medication with weakness rather than treatment.

They may believe that a “real” weight-loss effort should involve diet and exercise alone.

2. Fear of Being Judged

A man who loses substantial weight may hear:

“You took the easy route.”

That comment can undermine what may have been a difficult and medically supervised process.

3. Concern About Side Effects

GLP-1 and related medications can cause gastrointestinal side effects such as nausea, vomiting, diarrhea or constipation.

More serious adverse effects can also occur with these medicines, which is why appropriate medical supervision matters.

For example, the current FDA prescribing information for Wegovy contains important warnings and contraindications, including a boxed warning related to thyroid C-cell tumors observed in rodents.

4. Cost

Some patients may face significant out-of-pocket costs depending on insurance coverage, eligibility and the specific medication.

Cost can become an important factor in whether someone starts or continues treatment.

5. Fear That the Medication May Not Work

Some men have already tried multiple diets.

If those attempts produced temporary results followed by weight regain, starting another treatment can feel risky.

They may prefer to wait until they see results before telling anyone.

Silence Can Create Another Problem

There is a practical reason men should not feel compelled to keep their treatment secret.

Their healthcare professionals need to know what medications they are taking.

Weight-loss drugs can interact with other treatments or may require special consideration depending on a person’s medical history.

The BBC report quoted a public-health researcher who warned that men may be less likely to seek medical advice or may delay doing so.

That is where privacy becomes potentially harmful.

Keeping a medication private from friends is one thing.

Keeping it hidden from your doctor is another.

GLP-1 Medicines Are Not a Substitute for Lifestyle Changes

There is also an important misconception to avoid.

Taking a weight-loss medication does not mean lifestyle changes no longer matter.

The FDA-approved labeling for Zepbound specifies its use alongside a reduced-calorie diet and increased physical activity for chronic weight management in appropriate adults. (FDA Access Data)

The same broader principle applies to obesity treatment generally.

Medication can be one part of a treatment plan.

Nutrition, physical activity, sleep, behavior and long-term weight maintenance still matter.

What Happens When the Weight Starts Coming Off?

For some men, successful weight loss can change the conversation.

The BBC report described men who initially avoided discussing their treatment but became more open after seeing results.

That creates an interesting psychological effect.

Before treatment:

“What if people think I’m cheating?”

After successful weight loss:

“I know this treatment helped me.”

The second perspective can gradually replace the first.

Men Need Better Conversations About Obesity

The solution is not to convince every man to take a GLP-1 medication.

The solution is to remove the shame from discussing evidence-based treatment.

Some men will benefit from lifestyle changes alone.

Some may require medication.

Some may need a combination of medication, nutrition support, exercise and behavioral changes.

Others may have medical conditions or medications contributing to weight gain and need a completely different approach.

The important thing is getting the right treatment for the individual.

What Should a Man Consider Before Starting a Weight-Loss Drug?

Anyone considering a prescription weight-loss medication should have a proper medical discussion first.

Important questions include:

  • Is the medication appropriate for me?
  • What benefits should I realistically expect?
  • What side effects should I watch for?
  • Could it interact with my other medications?
  • How will my progress be monitored?
  • What happens if I stop taking it?
  • What lifestyle changes should accompany treatment?
  • What will the treatment cost?

These questions are far more useful than asking whether using medication is “cheating.”

The Bigger Issue Is Not the Injection

The real issue is how society thinks about obesity.

For decades, people with obesity have often been told that weight loss is simply a matter of discipline.

Modern obesity medicine paints a more complicated picture.

Appetite regulation, metabolism, genetics, environment, sleep, medications, mental health and socioeconomic factors can all influence body weight.

That does not remove personal responsibility.

It puts responsibility into a more realistic medical context.

A Weight-Loss Drug Does Not Define a Man

A man’s health should not be measured by whether he lost weight without medication.

It should be measured by whether he is moving toward better health.

If a qualified healthcare professional determines that medication is appropriate, using it does not make someone weak.

It means he is addressing a health problem with an available medical option.

And if treatment helps someone become more active, improve metabolic health and reduce obesity-related health risks, that outcome deserves to be taken seriously.

Final Takeaway

The growing use of GLP-1 medications is changing how people approach weight management.

But the conversation is not only about drugs.

It is also about shame, masculinity and the pressure men feel to solve health problems alone.

The experiences reported by BBC show that many men may be using weight-loss medications quietly because they fear being judged.

New research suggests that stigma surrounding anti-obesity medication is not imaginary. People can face negative assumptions about the amount of effort involved in medically assisted weight loss.

The better message is simple:

Using an appropriate medical treatment for obesity is not cheating.

The decision should be based on medical need, safety, expected benefit and professional guidance.

And perhaps the most important change is this:

Men should feel as comfortable talking about obesity treatment as they do about treating any other chronic health condition.

Frequently Asked Questions

Why don’t men talk about using weight-loss drugs?

Some men may avoid discussing GLP-1 medications because of stigma, fear of appearing weak, concerns about being accused of taking a shortcut, cost or worries about side effects.

Are GLP-1 weight-loss drugs only for women?

No. FDA-approved weight-management medicines such as Wegovy and Zepbound can be prescribed to eligible adults regardless of sex. Eligibility depends on the medication’s approved indications and the individual’s medical circumstances. (FDA Access Data)

Are weight-loss injections cheating?

No. When appropriately prescribed, anti-obesity medication is a medical treatment. It should be viewed as one possible component of a comprehensive weight-management plan.

Is Mounjaro approved for weight loss?

In the United States, tirzepatide is approved under the brand name Zepbound for chronic weight management in eligible adults. Mounjaro is the tirzepatide product approved for type 2 diabetes. (FDA Access Data)

Is Wegovy safe for everyone?

No medication is appropriate for everyone. Wegovy has important contraindications, warnings and potential adverse effects. A healthcare professional should determine whether it is appropriate for an individual.

Should men tell their doctor if they are using a weight-loss drug?

Yes. Healthcare professionals should know about all prescription medicines and other treatments a patient is taking. This helps them assess safety, potential interactions and side effects.

Can weight-loss medication replace diet and exercise?

No. FDA-approved obesity treatments are generally used alongside lifestyle measures rather than as a replacement for healthy eating and physical activity.

Medical Disclaimer:

This article is for general educational purposes and discusses emerging research and current obesity-treatment issues. It is not a diagnosis or personal medical advice. Prescription weight-loss medications should be used only under appropriate healthcare supervision.

References

  1. BBC News — “Why don’t men talk about using weight-loss drugs?” — 17 August 2026. The original report and first-person accounts form the basis of this article’s discussion of stigma, secrecy and men’s experiences with weight-loss medication.
  2. U.S. Food and Drug Administration — Wegovy (semaglutide) prescribing information. Current FDA labeling covering indications, warnings and contraindications.
  3. U.S. Food and Drug Administration — Zepbound (tirzepatide) prescribing information. Current FDA information on chronic weight management and safety considerations.
  4. FDA — Zepbound approval for chronic weight management. FDA announcement describing its use with reduced-calorie diet and increased physical activity.
  5. Scientific Reports — Anti-obesity medication use and social penalties. 2026 research examining effort-based judgments and stigma toward GLP-1 medication users.
  6. Obesity Science & Practice — Public attitudes toward new anti-obesity medications. Research examining perceptions of obesity, willpower and newer anti-obesity treatments.